Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
33
CLLS Quote, Financials, Valuation and Earnings
Last price:
$1.47
Seasonality move
:
-11.94%
Day range:
$1.41 - $1.47
52-week range:
$1.10 - $2.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.99x
P/B ratio:
1.26x
Volume:
103.9K
Avg. volume:
49.4K
1-year change:
-46.19%
Market cap:
$146.4M
Revenue:
$41.5M
EPS (TTM):
-$0.61
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $51.1M | $30.3M | $19.2M | $755K | $41.5M | |
| Revenue Growth (YoY) | 236.12% | -40.57% | -36.83% | -96.06% | 5397.48% | |
| Cost of Revenues | $2M | $1.8M | $8.5M | $7.4M | $9.2M | |
| Gross Profit | $49.1M | $28.5M | $10.7M | -$6.7M | $32.3M | |
| Gross Profit Margin | 96.18% | 93.92% | 55.75% | -882.65% | 77.88% | |
| R&D Expenses | $77M | $117.8M | $97.5M | $87.6M | $90.5M | |
| Selling, General & Admin | $22.5M | $22.9M | $8.9M | $8.1M | $8.4M | |
| Other Inc / (Exp) | -$10.6M | $9.7M | $6.1M | -$16.4M | $19M | |
| Operating Expenses | $91.4M | $132M | $100.4M | $90.6M | $91.9M | |
| Operating Income | -$42.3M | -$103.5M | -$89.7M | -$97.3M | -$59.6M | |
| Net Interest Expenses | $680K | $3M | $15M | $2.8M | -- | |
| EBT. Incl. Unusual Items | -$53.6M | -$96.8M | -$98.6M | -$116.5M | -$36.8M | |
| Earnings of Discontinued Ops. | -$43.9M | -$28.4M | -$15.3M | $8.4M | -- | |
| Income Tax Expense | -- | -- | $87K | $371K | -- | |
| Net Income to Company | -$53.6M | -$96.7M | -$98.7M | -$116.8M | -$36.8M | |
| Minority Interest in Earnings | $16.4M | $10.9M | $7.9M | $7.4M | -- | |
| Net Income to Common Excl Extra Items | -$81.1M | -$114.2M | -$106.1M | -$101.1M | -$36.8M | |
| Basic EPS (Cont. Ops) | -$1.91 | -$2.55 | -$2.33 | -$1.77 | -$0.41 | |
| Diluted EPS (Cont. Ops) | -$1.91 | -$2.55 | -$2.33 | -$1.77 | -$0.41 | |
| Weighted Average Basic Share | $42.5M | $44.8M | $45.5M | $57M | $90.6M | |
| Weighted Average Diluted Share | $42.5M | $44.8M | $45.5M | $57M | $90.6M | |
| EBITDA | -$43.3M | -$78.4M | -$76.4M | -$92.6M | -$9.5M | |
| EBIT | -$51.2M | -$92.6M | -$94.8M | -$111.2M | -$29.3M | |
| Revenue (Reported) | $51.1M | $30.3M | $19.2M | $755K | $41.5M | |
| Operating Income (Reported) | -$42.3M | -$103.5M | -$89.7M | -$97.3M | -$59.6M | |
| Operating Income (Adjusted) | -$51.2M | -$92.6M | -$94.8M | -$111.2M | -$29.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $25.6M | $1.7M | $138K | $4.5M | $10.7M | |
| Revenue Growth (YoY) | -48.93% | -93.49% | -91.72% | 3181.16% | 135.31% | |
| Cost of Revenues | $8.1M | $3.4M | $2.1M | $2.3M | $2M | |
| Gross Profit | $17.5M | -$1.7M | -$2M | $2.2M | $8.6M | |
| Gross Profit Margin | 68.19% | -104.14% | -1452.17% | 48.21% | 81.09% | |
| R&D Expenses | $31M | $26.6M | $21.4M | $22.3M | $21.9M | |
| Selling, General & Admin | $8.8M | $3M | $2.8M | $2.4M | $2.3M | |
| Other Inc / (Exp) | -- | -- | -$4.2M | $26.1M | -$4.9M | |
| Operating Expenses | $37.4M | $27.5M | $21.4M | $23.1M | $22.8M | |
| Operating Income | -$19.9M | -$29.2M | -$23.4M | -$20.9M | -$14.2M | |
| Net Interest Expenses | -- | -- | $171K | -- | -- | |
| EBT. Incl. Unusual Items | -$15.3M | -$28.3M | -$27.8M | $5.4M | -$18.1M | |
| Earnings of Discontinued Ops. | -- | -$6.4M | -$4.7M | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$262K | -- | |
| Net Income to Company | -$15.3M | -$28.3M | -$27.8M | $5.6M | -$18.1M | |
| Minority Interest in Earnings | $3.5M | $2.8M | $2.5M | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.9M | -$31.9M | -$30.1M | $5.6M | -$18.1M | |
| Basic EPS (Cont. Ops) | -$0.28 | -$0.70 | -$0.58 | $0.08 | -$0.18 | |
| Diluted EPS (Cont. Ops) | -$0.28 | -$0.70 | -$0.58 | -$0.15 | -$0.18 | |
| Weighted Average Basic Share | $42.9M | $45.5M | $51.5M | $71.8M | $100.2M | |
| Weighted Average Diluted Share | $42.9M | $45.5M | $51.5M | $103.1M | $100.2M | |
| EBITDA | -$10.4M | -$22.1M | -$22.5M | $11.7M | -$11.3M | |
| EBIT | -$14.2M | -$27M | -$26.9M | $7.2M | -$16.2M | |
| Revenue (Reported) | $25.6M | $1.7M | $138K | $4.5M | $10.7M | |
| Operating Income (Reported) | -$19.9M | -$29.2M | -$23.4M | -$20.9M | -$14.2M | |
| Operating Income (Adjusted) | -$14.2M | -$27M | -$26.9M | $7.2M | -$16.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $25.7M | $6.4M | $17.6M | $5.1M | $47.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5.6M | -$5.7M | $7.2M | $7.6M | $8.9M | |
| Gross Profit | $20.1M | $12.1M | $10.4M | -$2.5M | $38.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $87.4M | $113.2M | $92.3M | $88.6M | $90.1M | |
| Selling, General & Admin | $18.9M | $19.9M | $8.7M | $7.7M | $8M | |
| Other Inc / (Exp) | -- | -- | $73K | $14.2M | -$12.1M | |
| Operating Expenses | $97.5M | $124.9M | $94.3M | $92.3M | $91.6M | |
| Operating Income | -$77.3M | -$112.8M | -$83.9M | -$94.8M | -$52.8M | |
| Net Interest Expenses | -- | $6.7M | $14.3M | $2.5M | -- | |
| EBT. Incl. Unusual Items | -$86.4M | -$109.7M | -$98.1M | -$83.1M | -$60.3M | |
| Earnings of Discontinued Ops. | -- | -$6.4M | -$13.6M | $13.1M | -- | |
| Income Tax Expense | -- | -- | $87K | $108K | $262K | |
| Net Income to Company | -$85.5M | -$109.7M | -$98.2M | -$83.4M | -$60.5M | |
| Minority Interest in Earnings | $16.4M | $10.3M | $7.5M | $4.9M | -- | |
| Net Income to Common Excl Extra Items | -$113.9M | -$134.2M | -$104.3M | -$65.3M | -$60.5M | |
| Basic EPS (Cont. Ops) | -$2.70 | -$3.35 | -$2.22 | -$1.11 | -$0.61 | |
| Diluted EPS (Cont. Ops) | -$2.70 | -$3.35 | -$2.22 | -$1.34 | -$0.61 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$76.6M | -$93.5M | -$76.4M | -$58.2M | -$32.5M | |
| EBIT | -$86.2M | -$108.8M | -$94.4M | -$76.9M | -$52.7M | |
| Revenue (Reported) | $25.7M | $6.4M | $17.6M | $5.1M | $47.6M | |
| Operating Income (Reported) | -$77.3M | -$112.8M | -$83.9M | -$94.8M | -$52.8M | |
| Operating Income (Adjusted) | -$86.2M | -$108.8M | -$94.4M | -$76.9M | -$52.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $25.6M | $1.7M | $138K | $4.5M | $10.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.1M | $3.4M | $2.1M | $2.3M | $2M | |
| Gross Profit | $17.5M | -$1.7M | -$2M | $2.2M | $8.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $31M | $26.6M | $21.4M | $22.3M | $21.9M | |
| Selling, General & Admin | $8.8M | $3M | $2.8M | $2.4M | $2.3M | |
| Other Inc / (Exp) | -- | -- | -$4.2M | $26.1M | -$4.9M | |
| Operating Expenses | $37.4M | $27.5M | $21.4M | $23.1M | $22.8M | |
| Operating Income | -$19.9M | -$29.2M | -$23.4M | -$20.9M | -$14.2M | |
| Net Interest Expenses | -- | -- | $171K | -- | -- | |
| EBT. Incl. Unusual Items | -$15.3M | -$28.3M | -$27.8M | $5.4M | -$18.1M | |
| Earnings of Discontinued Ops. | -- | -$6.4M | -$4.7M | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$262K | -- | |
| Net Income to Company | -$15.3M | -$28.3M | -$27.8M | $5.6M | -$18.1M | |
| Minority Interest in Earnings | $3.5M | $2.8M | $2.5M | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.9M | -$31.9M | -$30.1M | $5.6M | -$18.1M | |
| Basic EPS (Cont. Ops) | -$0.28 | -$0.70 | -$0.58 | $0.08 | -$0.18 | |
| Diluted EPS (Cont. Ops) | -$0.28 | -$0.70 | -$0.58 | -$0.15 | -$0.18 | |
| Weighted Average Basic Share | $42.9M | $45.5M | $51.5M | $71.8M | $100.2M | |
| Weighted Average Diluted Share | $42.9M | $45.5M | $51.5M | $103.1M | $100.2M | |
| EBITDA | -$10.4M | -$22.1M | -$22.5M | $11.7M | -$11.3M | |
| EBIT | -$14.2M | -$27M | -$26.9M | $7.2M | -$16.2M | |
| Revenue (Reported) | $25.6M | $1.7M | $138K | $4.5M | $10.7M | |
| Operating Income (Reported) | -$19.9M | -$29.2M | -$23.4M | -$20.9M | -$14.2M | |
| Operating Income (Adjusted) | -$14.2M | -$27M | -$26.9M | $7.2M | -$16.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $241.1M | $185.6M | $89.8M | $136.7M | $143.3M | |
| Short Term Investments | $27.1M | $499K | $7.9M | $67.1M | $117.1M | |
| Accounts Receivable, Net | $5.2M | $20.4M | $772K | $569K | $6.7M | |
| Inventory | $1.6M | -- | -- | -- | -- | |
| Prepaid Expenses | $14.1M | $8.2M | $6.2M | $5.7M | $3.4M | |
| Other Current Assets | $12.2M | $50K | $538K | $345K | $298K | |
| Total Current Assets | $315.4M | $225.4M | $143.8M | $233M | $287.1M | |
| Property Plant And Equipment | $145.5M | $148.3M | $107.9M | $92.7M | $75.9M | |
| Long-Term Investments | $7M | $6.5M | $8.8M | $7.9M | $7.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $1.6M | $1.9M | $718K | $672K | $1.1M | |
| Other Long-Term Assets | -$1K | $3K | -- | -$1K | $11.6M | |
| Total Assets | $469.5M | $382.1M | $261.2M | $334.3M | $383.5M | |
| Accounts Payable | $24.6M | $23.8M | $21.5M | $19.1M | $18.7M | |
| Accrued Expenses | $13M | $12.5M | $9.4M | $9.4M | $8.8M | |
| Current Portion Of Long-Term Debt | -- | $2.2M | $5M | $5.2M | $4.8M | |
| Current Portion Of Capital Lease Obligations | $6.7M | $8.3M | $7.9M | $8.5M | $8.4M | |
| Other Current Liabilities | $6.1M | $1.3M | $15.7M | $978K | $12.5M | |
| Total Current Liabilities | $52M | $49.3M | $63M | $155.1M | $166.3M | |
| Long-Term Debt | $24.2M | $18.8M | $13.6M | $28.4M | $44M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $160.6M | $145.6M | $135.3M | $249.6M | $252.5M | |
| Common Stock | $2.8M | $2.9M | $3M | $4.4M | $5.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $283.8M | $221.3M | $118M | $84.7M | $131M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $25.1M | $15.2M | $8M | -- | -- | |
| Total Equity | $308.8M | $236.5M | $125.9M | $84.7M | $131M | |
| Total Liabilities and Equity | $469.5M | $382.1M | $261.2M | $334.3M | $383.5M | |
| Cash and Short Terms | $268.2M | $186.1M | $97.7M | $203.8M | $260.3M | |
| Total Debt | $24.2M | $21M | $18.5M | $33.6M | $48.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $207.5M | $154.9M | $83.5M | $123M | $127.6M | |
| Short Term Investments | $18.4M | -- | $4.6M | $26.2M | $114.1M | |
| Accounts Receivable, Net | $6.4M | $21.8M | $1.1M | $16M | $7.9M | |
| Inventory | $5.3M | -- | -- | -- | -- | |
| Prepaid Expenses | $13.2M | $6.2M | $6.8M | $3.9M | $2.3M | |
| Other Current Assets | $6.5M | -$147K | $373K | $274K | $295K | |
| Total Current Assets | $272.4M | $195.2M | $137.4M | $258.1M | $271.8M | |
| Property Plant And Equipment | $146.6M | $143.8M | $105.1M | $87.8M | $72.9M | |
| Long-Term Investments | $22.1M | $6.6M | $8.2M | $2.3M | $2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $1.6M | -- | -- | -- | $242K | |
| Other Long-Term Assets | $1K | -$1K | $1K | $4.7M | $2.3M | |
| Total Assets | $442.7M | $347.2M | $251.4M | $354.5M | $364.1M | |
| Accounts Payable | $24.7M | $20.9M | $22.3M | $16.1M | $17.2M | |
| Accrued Expenses | $9.6M | $8.1M | $5.6M | $5.7M | $5.4M | |
| Current Portion Of Long-Term Debt | -- | $3.5M | $5.1M | $5M | $5M | |
| Current Portion Of Capital Lease Obligations | $7M | $8.4M | $8.2M | $8.4M | $7.9M | |
| Other Current Liabilities | $4.2M | $10.2M | $17.9M | $1.6M | $12.9M | |
| Total Current Liabilities | $46.9M | $52.3M | $60.5M | $158.4M | $162.6M | |
| Long-Term Debt | $23.3M | $17.1M | $12.6M | $40.2M | $45.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $153M | $144.1M | $130.9M | $263.9M | $247.9M | |
| Common Stock | $2.8M | $2.9M | $3.5M | $4.4M | $5.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $27.8M | $12M | $6.8M | -- | -- | |
| Total Equity | $289.7M | $203.1M | $120.5M | $90.6M | $116.2M | |
| Total Liabilities and Equity | $442.7M | $347.2M | $251.4M | $354.5M | $364.1M | |
| Cash and Short Terms | $225.9M | $154.9M | $88.2M | $149.2M | $241.7M | |
| Total Debt | $23.3M | $20.6M | $17.6M | $45.2M | $50.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$53.6M | -$96.7M | -$98.7M | -$116.8M | -$36.8M | |
| Depreciation & Amoritzation | $7.8M | $14.2M | $18.4M | $18.5M | $19.8M | |
| Stock-Based Compensation | $10M | $11.5M | $6M | $5.2M | $3.2M | |
| Change in Accounts Receivable | -$3.2M | -$12.4M | -$9M | -$4M | $45.9M | |
| Change in Inventories | $100K | $215K | -- | -- | -- | |
| Cash From Operations | -$80.3M | -$104.6M | -$87.4M | -$24.7M | $23M | |
| Capital Expenditures | $44.4M | $18.6M | $2.4M | $1.1M | $3.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.3M | $7.3M | -$2.8M | -$15.5M | -$102.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $24.2M | -- | $5.8M | $29.7M | $23.2M | |
| Long-Term Debt Repaid | -$4.7M | -$10.6M | -$12.4M | -$16.2M | -$16.1M | |
| Repurchase of Common Stock | -- | -- | -$569K | -- | -- | |
| Other Financing Activities | -$1K | $1K | -- | $1K | -- | |
| Cash From Financing | $27.3M | $47.5M | $1.1M | $82.9M | $89.1M | |
| Beginning Cash (CF) | $340.5M | $241.1M | $185.6M | $93.2M | $136.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$107.3M | -$49.8M | -$89.1M | $42.6M | $9.3M | |
| Ending Cash (CF) | $241.1M | $185.6M | $93.2M | $136.7M | $143.3M | |
| Levered Free Cash Flow | -$124.7M | -$123.1M | -$89.9M | -$25.8M | $19.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.3M | -$28.3M | -$27.8M | $5.6M | -$18.1M | |
| Depreciation & Amoritzation | $3.8M | $4.9M | $4.5M | $4.6M | $4.9M | |
| Stock-Based Compensation | $30K | $2.3M | $1.6M | $887K | $976K | |
| Change in Accounts Receivable | -$3.4M | -$1.4M | -$4.4M | -$15.7M | -$1.6M | |
| Change in Inventories | -$3.7M | -- | -- | -- | -- | |
| Cash From Operations | -$40.9M | -$36.6M | -$28.3M | -$23.3M | -$17.2M | |
| Capital Expenditures | $8.2M | $626K | $213K | $255K | $395K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $307K | -$982K | $230K | -$2.1M | $4.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $16.3M | -- | |
| Long-Term Debt Repaid | -$2.2M | -$2.8M | -$4M | -$4.1M | -$3.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | $1K | |
| Cash From Financing | $9.8M | $7.7M | $19.8M | $11.9M | -$4.1M | |
| Beginning Cash (CF) | $241.1M | $185.6M | $93.2M | $136.7M | $143.3M | |
| Foreign Exchange Rate Adjustment | -$2.9M | -$852K | $669K | -$267K | $1.4M | |
| Additions / Reductions | -$30.8M | -$29.9M | -$8.3M | -$13.5M | -$17M | |
| Ending Cash (CF) | $207.5M | $154.9M | $85.6M | $123M | $127.6M | |
| Levered Free Cash Flow | -$49.1M | -$37.2M | -$28.5M | -$23.6M | -$17.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$85.5M | -$109.7M | -$98.2M | -$83.4M | -$60.5M | |
| Depreciation & Amoritzation | $9.5M | $15.3M | $18M | $18.6M | $20.2M | |
| Stock-Based Compensation | $5.3M | $13.8M | $5.3M | $4.5M | $3.3M | |
| Change in Accounts Receivable | -$5.5M | -$10.4M | -$12M | -$15.3M | $60M | |
| Change in Inventories | -$2.9M | -- | -- | -- | -- | |
| Cash From Operations | -$122.6M | -$100.2M | -$79.2M | -$19.7M | $29.1M | |
| Capital Expenditures | $44.7M | $11M | $2M | $1.1M | $4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5.5M | $6M | -$1.5M | -$17.8M | -$96.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $5.8M | $45.9M | $7M | |
| Long-Term Debt Repaid | -$5.1M | -$11.2M | -$13.6M | -$16.3M | -$15.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $39M | $45.4M | $13.2M | $75M | $73.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$89.1M | -$48.8M | -$67.5M | $37.5M | $5.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$167.3M | -$111.2M | -$81.2M | -$20.9M | $25.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$15.3M | -$28.3M | -$27.8M | $5.6M | -$18.1M | |
| Depreciation & Amoritzation | $3.8M | $4.9M | $4.5M | $4.6M | $4.9M | |
| Stock-Based Compensation | $30K | $2.3M | $1.6M | $887K | $976K | |
| Change in Accounts Receivable | -$3.4M | -$1.4M | -$4.4M | -$15.7M | -$1.6M | |
| Change in Inventories | -$3.7M | -- | -- | -- | -- | |
| Cash From Operations | -$40.9M | -$36.6M | -$28.3M | -$23.3M | -$17.2M | |
| Capital Expenditures | $8.2M | $626K | $213K | $255K | $395K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $307K | -$982K | $230K | -$2.1M | $4.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $16.3M | -- | |
| Long-Term Debt Repaid | -$2.2M | -$2.8M | -$4M | -$4.1M | -$3.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | $1K | |
| Cash From Financing | $9.8M | $7.7M | $19.8M | $11.9M | -$4.1M | |
| Beginning Cash (CF) | $241.1M | $185.6M | $93.2M | $136.7M | $143.3M | |
| Foreign Exchange Rate Adjustment | -$2.9M | -$852K | $669K | -$267K | $1.4M | |
| Additions / Reductions | -$30.8M | -$29.9M | -$8.3M | -$13.5M | -$17M | |
| Ending Cash (CF) | $207.5M | $154.9M | $85.6M | $123M | $127.6M | |
| Levered Free Cash Flow | -$49.1M | -$37.2M | -$28.5M | -$23.6M | -$17.6M | |
Get CLLS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLLS
Sector
P/E ratio
--
24.37x
PEG ratio
--
0.00x
P/B ratio
1.26x
1.74x
Price / LTM sales
2.99x
1.65x
Growth Metrics
CLLS
Sector
Revenue growth
135.31%
5.12%
Earnings growth
--
7.46%
Revenue (5-year growth)
22.27%
8.25%
Earnings forecast
-$0.16
-$0.20
Profitability
CLLS
Sector
Profitability FY 2024
$32.3M
$51.2M
Return on invested capital
-35.55%
-14.95%
Return on assets
-15.89%
-12.07%
Return on equity
-49.15%
-17.16%
Earnings Date
Last Earnings Date
May
12
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
11
Balance Sheet
CLLS
Sector
Total cash
$241.7M
$38.3M
Short term investments
$117.1M
$33.2M
Total assets
$383.5M
$118.2M
Long term debt
$50.8M
$8.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
